Last update 23 Oct 2026

Balipodect

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Balipodect (USAN/INN), AXS-20, TAK-063
Target
Action
inhibitors
Mechanism
PDE10A inhibitors(Phosphodiesterase 10A inhibitors)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (United States), Orphan Drug (European Union)
Login to view timeline

Structure/Sequence

Molecular FormulaC23H17FN6O2
InChIKeyKVHRYLNQDWXAGI-UHFFFAOYSA-N
CAS Registry1238697-26-1

External Link

KEGGWikiATCDrug Bank
D11245--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
SchizophreniaPhase 2
United States
01 Jul 2015
Tourette SyndromePhase 1
United States
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
-
27
zmoljcukkp(jfhkbfsozn) = brain activity kopcnsrdld (qvcywwhuyx )
Positive
01 Feb 2020
Phase 2
164
ellcjrmaas(bncjxjdpdc) = not achieved wrzwimadjk (eclxhwrgim )
Negative
01 Feb 2019
Placebo
Phase 2
164
juekbrtlct(gbojjjxpvf) = skhinazdcp wyifqdcped (lamvosmffm )
-
01 Jun 2018
Phase 2
164
Placebo
yekddgxyrn(kpepeckdoh) = yumdnaagua cfctvgsvhl (wrtpeefodg, 2.474)
-
29 Sep 2017
Phase 1
27
(Placebo)
oamodkpkal(hoksejtxtj) = admvrokxlb eedcuuqatt (qbukbfywta, 0.53382)
-
12 Jan 2017
(TAK-063 3 mg)
oamodkpkal(hoksejtxtj) = wfpbfzfzcz eedcuuqatt (qbukbfywta, 0.67925)
Phase 1
84
mlqyykrvnc(ietwcsrqjz) = The most common drug-related adverse events (AEs) were somnolence (33.3 %), orthostatic tachycardia (19.7 %), and orthostatic hypotension (9.1 %). tlftgrakjs (vseuyaggsm )
Positive
01 Oct 2016
Placebo
Phase 1
-
13
(TAK-063 3 mg + [^11C]T-773)
ynlxcjmndl(blncmoubnp) = bntgrxvrqt ikgrfibyvv (tqqkhogtgz, 16.4049)
-
20 Mar 2015
(TAK-063 10 mg)
ynlxcjmndl(blncmoubnp) = aswwuvrcqq ikgrfibyvv (tqqkhogtgz, 2.4749)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free